Kathrin Eschke

A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations

Federico Bertoglio, Viola Fühner, Maximilian Ruschig et al. · Cell Reports · 2021 · 103 citations · Full text

SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface

Federico Bertoglio, Doris Meier, Nora Langreder et al. · Nature Communications · 2021 · 96 citations · Full text

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

Sylvia Rothenberger, Daniel L. Hurdiss, Marcel Walser et al. · Nature Biotechnology · 2022 · 56 citations · Full text

Attenuation of a very virulent Marek's disease herpesvirus (MDV) by codon pair bias deoptimization

Kathrin Eschke, Jakob Trimpert, Nikolaus Osterrieder et al. · PLoS Pathogens · 2018 · 54 citations · Full text

Live attenuated virus vaccine protects against SARS-CoV-2 variants of concern B.1.1.7 (Alpha) and B.1.351 (Beta)

Jakob Trimpert, Julia M. Adler, Kathrin Eschke et al. · Science Advances · 2021 · 44 citations · Full text

Vaccination, Vaccine Safety, Sars-cov-2 Variants +14